Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2010
08/04/2010CN101791354A Medicine composition used for interfering in and preventing birth defects and improving memory
08/04/2010CN101791352A Phenformin-containing traditional Chinese and western medicine composition
08/04/2010CN101791351A Glipizide-containing traditional Chinese and western medicine composition
08/04/2010CN101791350A Glibenclamide-containing traditional Chinese and western medicine composition
08/04/2010CN101791342A Uncaria extract and application thereof in preparing medicines for reducing blood fat and resisting cardiac hypertrophy
08/04/2010CN101791334A Circulation promoting agaricus blazei polysaccharide health-care capsule
08/04/2010CN101791332A Compound gingko health product solid preparation
08/04/2010CN101791324A Preparation process of Ilex latifolia Thunb extractive
08/04/2010CN101791321A Pharmaceutical composition with calcium supplementing effect
08/04/2010CN101791305A Formula for preparing preparation for treating diabetes from Mitiglinide calcium and production process thereof
08/04/2010CN101791302A Medicinal composition containing sodium ferulate and preparation method thereof
08/04/2010CN101791300A Acipimox push-pull osmotic pump controlled release tablet and preparation method thereof
08/04/2010CN101791297A Atorvastatin calcium oral disintegrating tablet and preparation method thereof
08/04/2010CN101791296A Orlistat tablets and preparation method thereof
08/04/2010CN101791290A Tetra-acetylated puerarin self-micro emulsifying medicament delivery system and preparation method thereof
08/04/2010CN101129497B Pharmaceutical uses of black-seed grass-seed oil of tuberculate fruit
08/04/2010CN101006860B Smoke-roasting bamboo salt and its making method
08/03/2010US7767881 Mixture of histamine receptor protein and histamine receptor antagonist
08/03/2010US7767685 8-pyrazolo-xanthine derivatives such as 2-[3-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-5-methyl-pyrazol-1-yl]-N-phenyl-acetamide, used for treating asthma, rhinitis, dermatitis, diabetes, tumors, reperfusion injuries, inflammatory bowel disease, autoimmune diseases and vison defects
08/03/2010US7767677 Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
08/03/2010US7767229 Use of poly diallyamine polymers
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2492724C The use of epidermal growth factor as a gastrointestinal therapeutic agent
08/03/2010CA2444269C Treatment of disorders secondary to organic impairments
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
08/03/2010CA2361949C Heparin, or heparin conjugate, islets of langerhans
08/03/2010CA2294101C A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
07/2010
07/29/2010WO2010085724A1 Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
07/29/2010WO2010085530A1 A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement
07/29/2010WO2010085528A1 Bridged and fused antidiabetic compounds
07/29/2010WO2010085525A1 Bridged and fused heterocyclic antidiabetic compounds
07/29/2010WO2010085522A1 Pentafluorosulpholane-containing antidiabetic compounds
07/29/2010WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases
07/29/2010WO2010084979A1 Benzodiazepin-2-on derivatives
07/29/2010WO2010084944A1 NOVEL PYRROLO[2,3-d]PYRIMIDINE COMPOUND
07/29/2010WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/29/2010WO2010084512A1 Novel oxime derivatives
07/29/2010WO2010084428A1 Substituted pyrazinone amides
07/29/2010WO2010084169A2 Fgf21 derivatives with albumin binder a-b-c-d-e- and their use
07/29/2010WO2010083937A1 Use of plant extracts comprising polyphenol for treating adiposity and diabetes mellitus type 2
07/29/2010WO2010083615A1 Compositions and methods for silencing apolipoprotein c-iii expression
07/29/2010WO2010083613A1 Phosphate management with small molecules
07/29/2010WO2010083570A1 Novel metabolic disease therapy
07/29/2010WO2010065802A3 Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds
07/29/2010WO2010065799A3 Amine substituted piperidine melanocortin receptor-specific compounds
07/29/2010WO2010049946A3 Thyroid receptor ligands
07/29/2010WO2010045656A3 Novel sglt2 inhibitor dosage forms
07/29/2010WO2010045417A3 Combination therapies for the treatment of obesity
07/29/2010WO2010045416A3 Combination therapies for the treatment of obesity
07/29/2010WO2010042633A3 Naringenin complexes and methods of use thereof
07/29/2010WO2010041138A3 Complex between human insulin and an amphiphilic polymer, and use of said complex for preparing a quick human insulin formulation
07/29/2010WO2010020307A3 Indazole-5-carboxylic acid hydrazide derivatives
07/29/2010WO2009158467A3 Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors
07/29/2010US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof
07/29/2010US20100190835 Pharmaceutical composition comprising aleglitazar
07/29/2010US20100190832 Mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and structural templates
07/29/2010US20100190831 Gpr120 receptor agonists and uses thereof
07/29/2010US20100190827 treating diseases responsive to cannabinoid receptor antagonism; using particular crystallization conditions, a novel stable crystalline form called form II is obtained
07/29/2010US20100190822 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)
07/29/2010US20100190818 Novel salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
07/29/2010US20100190817 Large substituent, non-phenolic amine opioids
07/29/2010US20100190813 Spiro [piperidine-4- 4' -thieno [3,2-c] pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
07/29/2010US20100190811 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
07/29/2010US20100190808 Tricyclic Compounds As Modulators of TNF-alpha Synthesis
07/29/2010US20100190802 Carboxamide compounds and methods for using the same
07/29/2010US20100190801 Triazolopyridine derivatives as inhibitors of lipases and phospholipases
07/29/2010US20100190793 Compositions for affecting weight loss
07/29/2010US20100190790 Sigma receptor inhibitors
07/29/2010US20100190789 Piperidine/piperazine derivatives
07/29/2010US20100190781 Sigma receptor inhibitors
07/29/2010US20100190780 Sigma receptor inhibitors
07/29/2010US20100190773 Anti-Cytokine Heterocyclic Compounds
07/29/2010US20100190772 Substituted Azepine Derivatives As Serotonin Receptor Modulators
07/29/2010US20100190769 Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
07/29/2010US20100190768 Novel fused pyrole derivative
07/29/2010US20100190763 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
07/29/2010US20100190762 Triazolyl phenyl benzenesulfonamides
07/29/2010US20100190759 Nk 1 antagonists
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/29/2010US20100190747 Fused ring compound and use thereof
07/29/2010US20100190744 Compositions and methods of treating viral infections
07/29/2010US20100190739 Rapidly Dissolving Vitamin Formulation and Methods of Using the Same
07/29/2010US20100190732 Use of pterosin compounds for treating diabetes and obesity
07/29/2010US20100190722 Substance p and thyrotropin releasing hormone for therapeutic applications
07/29/2010US20100190718 Methods for preventing or treating mitochondrial permeability transition
07/29/2010US20100190717 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
07/29/2010US20100190715 Stable Formulations of Peptides
07/29/2010US20100190713 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent
07/29/2010US20100190711 Big gastrin i as a therapeutic agent
07/29/2010US20100190708 Composition for amelioration of body lipid
07/29/2010US20100190706 Stable Non-Aqueous Pharmaceutical Compositions
07/29/2010US20100190701 Glucagon/glp-1 receptor co-agonists
07/29/2010US20100190700 Methods and compositions for treating hypoglycemic disorders
07/29/2010US20100190699 GLUCAGON ANALOGS EXHIBITING ENHANCED SOLUBILITY IN PHYSIOLOGICAL pH BUFFERS
07/29/2010US20100190697 Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass
07/29/2010US20100190687 Pyrimidinone derivatives and methods of use thereof
07/29/2010US20100190686 Novel secreted proteins of adipocytes for diagnostic purposes
07/29/2010US20100189830 Sweet Gum Fruit Extract as a Therapeutic Agent
1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 1298